Untitled Document
PROFESSOR ANNA A. SHVEDOVA, PhD, Dr. Sc.

Lead Research Physiologist, Pathology &Physiology Research Branch, National Institute for Occupational Safety and Health /CDC and Adjunct Professor, Department Physiology and Pharmacology, School of Medicine, West Virginia University.

Dr. Shvedova’s specialty interests include mechanism(s) of chronic lung and skin diseases caused by industrial chemicals, vapors, particulates and nanomaterials. Dr. Shvedova’s lab is investigating the toxicology of nanomaterials and mechanism(s) of adverse effects of nanoscale products, development of novel cellular and animal models, and biomarkers of exposures. Dr. Shvedova has published over 140 scientific papers and book chapters in the toxicology field.  She is co-editor of “Adverse Effects of Engineered Nanomaterials: Exposure, Toxicology, and Impact on Human Health” book (Elsevier, 2012). She was founder and first president Dermal Toxicology Specialty Section of the Society of Toxicology (SOT). She served as the PI of WP4 of the NANOMMUNE program project (2008-2011) and currently is the partner of EU FW7 Biological Foundation for the Safety Classification of Engineered Nanomaterials/ENM: Systems Biology Approaches to Understand Interactions of ENM with Living Organisms and the Environment “Nanosolitions” program project (2012-2015). Dr. Shvedova has been honored with SOT Public Communication Award in 2001; Women in Toxicology SOT Award in 2006; Alice Hamilton NIOSH Award for paper of the year in Occupational Safety and Health in 2006, 2009; Bullard-Sherwood Award for Research for Practice in 2011. She has been serving as scientific advisor of a number of activities focused on dissemination of nanotechnologies to the general public. Dr. Shvedova is board member for Skin Notation/NIOSH/CDC, Associate Editor of Toxicology & Apply Pharmacology; Editorial Board for Regulatory Toxicology. She is on advisory board for US Army, Air Force, NASA, and NRC/Working Environment/Nanosafety, Denmark program projects.